Gain Therapeutics, Inc. (GANX)
NASDAQ: GANX · Real-Time Price · USD
2.750
-0.090 (-3.17%)
At close: Mar 12, 2026, 4:00 PM EDT
2.760
+0.010 (0.36%)
After-hours: Mar 12, 2026, 7:46 PM EDT
Gain Therapeutics Market Cap
Gain Therapeutics has a market cap or net worth of $105.77 million as of March 12, 2026. Its market cap has increased by 107.69% in one year.
Market Cap
105.77M
Enterprise Value
99.11M
1-Year Change
107.69%
Ranking
Category
Stock Price
$2.75
Market Cap Chart
Since the IPO on March 18, 2021, Gain Therapeutics's market cap has decreased from $124.64M to $105.77M, a decrease of -15.14%. That is a compound annual growth rate of -3.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 11, 2026 | 109.23M | -11.80% |
| Dec 31, 2025 | 123.85M | 116.16% |
| Dec 31, 2024 | 57.29M | 16.03% |
| Dec 29, 2023 | 49.38M | 32.75% |
| Dec 30, 2022 | 37.19M | -42.34% |
| Dec 31, 2021 | 64.51M | -48.25% |
| Mar 18, 2021 | 124.64M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Inovio Pharmaceuticals | 116.80M |
| Gossamer Bio | 115.59M |
| Coya Therapeutics | 113.72M |
| Codexis | 113.36M |
| Agenus | 111.55M |
| Aardvark Therapeutics | 111.48M |
| Oncolytics Biotech | 109.76M |
| Turn Therapeutics | 106.89M |